nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—HTR1B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0373	0.0373	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0307	0.0307	CbGpPWpGaD
Penbutolol—HTR1A—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0284	0.0284	CbGpPWpGaD
Penbutolol—HTR1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0262	0.0262	CbGpPWpGaD
Penbutolol—HTR1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0254	0.0254	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0245	0.0245	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0239	0.0239	CbGpPWpGaD
Penbutolol—HTR1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0237	0.0237	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0234	0.0234	CbGpPWpGaD
Penbutolol—HTR1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.022	0.022	CbGpPWpGaD
Penbutolol—HTR1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0214	0.0214	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0209	0.0209	CbGpPWpGaD
Penbutolol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0204	0.0204	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0202	0.0202	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0199	0.0199	CbGpPWpGaD
Penbutolol—HTR1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0199	0.0199	CbGpPWpGaD
Penbutolol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0198	0.0198	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0194	0.0194	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0189	0.0189	CbGpPWpGaD
Penbutolol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0184	0.0184	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.018	0.018	CbGpPWpGaD
Penbutolol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0175	0.0175	CbGpPWpGaD
Penbutolol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0171	0.0171	CbGpPWpGaD
Penbutolol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.017	0.017	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0168	0.0168	CbGpPWpGaD
Penbutolol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0166	0.0166	CbGpPWpGaD
Penbutolol—HTR1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0166	0.0166	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0163	0.0163	CbGpPWpGaD
Penbutolol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0159	0.0159	CbGpPWpGaD
Penbutolol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0155	0.0155	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0152	0.0152	CbGpPWpGaD
Penbutolol—HTR1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0139	0.0139	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0132	0.0132	CbGpPWpGaD
Penbutolol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0129	0.0129	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0126	0.0126	CbGpPWpGaD
Penbutolol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0111	0.0111	CbGpPWpGaD
Penbutolol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.011	0.011	CbGpPWpGaD
Penbutolol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0109	0.0109	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0106	0.0106	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00906	0.00906	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0088	0.0088	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00574	0.00574	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00544	0.00544	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00529	0.00529	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00505	0.00505	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00492	0.00492	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00491	0.00491	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00457	0.00457	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00433	0.00433	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0042	0.0042	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00415	0.00415	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00403	0.00403	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00402	0.00402	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00394	0.00394	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00391	0.00391	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00391	0.00391	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00385	0.00385	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00382	0.00382	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00375	0.00375	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00374	0.00374	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00365	0.00365	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00364	0.00364	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00356	0.00356	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00348	0.00348	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00345	0.00345	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00337	0.00337	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00335	0.00335	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0033	0.0033	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0033	0.0033	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00327	0.00327	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0032	0.0032	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0032	0.0032	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0032	0.0032	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00312	0.00312	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00305	0.00305	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00298	0.00298	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00298	0.00298	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00274	0.00274	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00263	0.00263	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00257	0.00257	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00255	0.00255	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00255	0.00255	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00251	0.00251	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00249	0.00249	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00249	0.00249	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00244	0.00244	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00244	0.00244	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00237	0.00237	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00232	0.00232	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00227	0.00227	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00218	0.00218	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00214	0.00214	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00209	0.00209	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00209	0.00209	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00186	0.00186	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00181	0.00181	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00169	0.00169	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00168	0.00168	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00166	0.00166	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00164	0.00164	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00163	0.00163	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00159	0.00159	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00153	0.00153	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00148	0.00148	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00145	0.00145	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00144	0.00144	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00142	0.00142	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00141	0.00141	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00138	0.00138	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00135	0.00135	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00134	0.00134	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00132	0.00132	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00131	0.00131	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00131	0.00131	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00129	0.00129	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00128	0.00128	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00128	0.00128	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00125	0.00125	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00122	0.00122	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00119	0.00119	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00118	0.00118	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00117	0.00117	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00107	0.00107	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000999	0.000999	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00097	0.00097	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00094	0.00094	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000919	0.000919	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000904	0.000904	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000899	0.000899	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000853	0.000853	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000835	0.000835	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000816	0.000816	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000796	0.000796	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000779	0.000779	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000773	0.000773	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000761	0.000761	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000756	0.000756	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000739	0.000739	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00072	0.00072	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000704	0.000704	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000688	0.000688	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000633	0.000633	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000504	0.000504	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000493	0.000493	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000482	0.000482	CbGpPWpGaD
